Ken Griffin Bionano Genomics, Inc. Call Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$0.57 - $1.16 $185,933 - $378,392	-326,200 Reduced 45.56%	389,800 $237,000
Q1 2023 May 15, 2023	SELL	$1.06 - $1.97 $202,248 - $375,876	-190,800 Reduced 21.04%	716,000 $794,000
Q4 2022 Feb 14, 2023	BUY	$1.4 - $25.4 $292,320 - $5.3 Million	208,800 Added 29.91%	906,800 $1.32 Million
Q3 2022 Nov 14, 2022	BUY	$0.36 - $36.0 $91,008 - $9.1 Million	252,800 Added 56.78%	698,000 $1.28 Million

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.